44911-0367 NDC - OSTEOPAR (EQUISETUM HYEMALE, SYMPHYTUM OFFICINALE, CALCAREA CARBONICA, CALCAREA FLUORICA, CALCAREA PHOSPHORICA, MEDULLA OSSIS SUIS, OSSA SEPIA, SILICEA, HEKLA LAVA)

Drug Information

Product NDC: 44911-0367

Proprietary Name: Osteopar

Non Proprietary Name: Equisetum Hyemale, Symphytum Officinale, Calcarea Carbonica, Calcarea Fluorica, Calcarea Phosphorica, Medulla Ossis Suis, Ossa Sepia, Silicea, Hekla Lava

Active Ingredient(s):
  • 3 [hp_X]/mL EQUISETUM HYEMALE;
  • 6 [hp_X]/mL COMFREY ROOT;
  • 12 [hp_X]/mL OYSTER SHELL CALCIUM CARBONATE, CRUDE;
  • 12 [hp_X]/mL CALCIUM FLUORIDE;
  • 12 [hp_X]/mL TRIBASIC CALCIUM PHOSPHATE;
  • 12 [hp_X]/mL SUS SCROFA BONE MARROW;
  • 12 [hp_X]/mL SEPIA ESCULENTA BONE;
  • 12 [hp_X]/mL SILICON DIOXIDE;
  • 15 [hp_X]/mL HEKLA LAVA


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Labeler Information

Labeler Name: Energique, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:6/16/2016

Package Information

No. Package Code Package Description Billing Unit
144911-0367-130 mL in 1 BOTTLE, DROPPER (44911-0367-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC44911-0367The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEOsteoparThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEEquisetum Hyemale, Symphytum Officinale, Calcarea Carbonica, Calcarea Fluorica, Calcarea Phosphorica, Medulla Ossis Suis, Ossa Sepia, Silicea, Hekla LavaThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE6/16/2016This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEEnergique, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEEQUISETUM HYEMALE; COMFREY ROOT; OYSTER SHELL CALCIUM CARBONATE, CRUDE; CALCIUM FLUORIDE; TRIBASIC CALCIUM PHOSPHATE; SUS SCROFA BONE MARROW; SEPIA ESCULENTA BONE; SILICON DIOXIDE; HEKLA LAVAThis is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH3; 6; 12; 12; 12; 12; 12; 12; 15 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 8/16/2021